1-3 of 3
Matthieu Wemeau, MD
Close
Sort by
Journal Articles

Procoagulant Platelet-Derived Microparticles Are Lower in Calreticulin-Than in-JAK2-Mutated Essential Thrombocythemia

Agnes Charpentier, MD, Nathalie Cambier, MD, Anne Bauters, Nathalie Trillot, MD, Matthieu Wemeau, MD, Olivier Nibourel, Veronique Tintillier, MD, Jean-Loup Demory, MD, Claude Preudhomme, PharmD, PhD, Brigitte Jude, MD PhD, Sophie Susen, MDPhD
Journal: Blood
Blood (2014) 124 (21): 110.
https://doi.org/10.1182/blood.V124.21.110.110
Published: 2014
Journal Articles

Safety Profile of Bortezomib Impacts Survival in Light Chain Amyloidosis

Zoé Van de Wyngaert, MD, Greg Vanoutryve, Guillemette Fouquet, MD, Stéphanie Guidez, Charles Herbaux, MD, Helene Demarquette, MD, Loic Renaud, Louis Terriou, MD, Marie Pierre Noel, MD, Marie Odile Petillon, MD, Bénédicte Hivert, MD, Matthieu Wemeau, MD, David Launay, MDPhD, Nicolas Lamblin, MD, Eric Hachulla, MD PhD, Thierry Facon, MD, Xavier Leleu, MD
Journal: Blood
Blood (2014) 124 (21): 5664.
https://doi.org/10.1182/blood.V124.21.5664.5664
Published: 2014
Journal Articles

Enumeration of Circulating Platelet-Derived Microparticles Clearly Separates PV and ET From Secondary Polycythemia or Thrombocytosis

Agnés Charpentier, MD, Stéphanie Devaux, Véronique Tintillier-Colin, MD, Matthieu Wemeau, MD, Judith Bruge-Debreu, MD, Nathalie Cambier, MD, Brigitte Jude, MD, PhD, Jean-Loup Demory, MD
Journal: Blood
Blood (2011) 118 (21): 1745.
https://doi.org/10.1182/blood.V118.21.1745.1745
Published: 2011